ISBER 2020 Program Series
ISBER

ISBER 2020

Educational Program Series

 

Pricing

Full Educational Series* $200 USD - member
$350 USD - non-member
Full Educational Series - Student/Technician* $120 USD - member
$210 USD - non-member
Single Webinar $50 USD - member
$75 USD - non-member
Corporate Workshop Free
Contributed Paper Sessions, workshops, and discussions Only accessible to individuals registered for the full educational series

*Purchase of the full webinar series gives you access to all live events, as well as all recordings.

Low and Middle Income Countries (LMICs):

Delegates in countries identified by the World Bank as Low and Lower-Middle Income are eligible for a 50% discount on meeting registration. Delegates in countries identified as Upper-Middle Income are eligible for a 25% discount on meeting registration. If you are eligible to receive a discount please contact info@isber.org.

To confirm the income classification for your country, please click here.

Please note that if you are also a technician or student, you will receive only the LMIC discount or the technician/student discount, whichever is higher.

Full Program Series

JUN – OCT, 2020

The full webinar series gives you access to all live events (webinars, workshops, contributed paper sessions, and discussions) as well as all recordings.

*Alternatively, you may register for individual sessions by clicking on the registration links in the "schedule" below.

June, 2020
June 24, 7:00am PT/10:00am ET/4:00pm CET/10:00pm CST

Registration closes on June 23, 2020 at 4:00 PM PT

Corporate Workshop: Monitoring Nucleic Acid Integrity During Long-Term Storage with Automated Electrophoresis

Presented by Elisa Viering (Agilent Technologies, Germany) and Monique Albert (Ontario Biobank, Canada)

Description: The DNA and RNA samples that you store in your biobank will be used for important research later. Our webinar will show you how to improve confidence in your sample quality, before and after samples go into storage using different automated electrophoresis platforms. In the webinar, we will have two retrospective analysis of sample storage conditions. Agilent’s nucleic acid QC portfolio streamlines the analysis of both DNA and RNA, including high-molecular weight genomic DNA through 165 kb. Each of Agilent’s automated electrophoresis instruments supply digital data with objective quality metrics that allows for easy data archiving and comparisons. Through the routine use of quality control, biobanks can evaluate past and current procedures for continuous improvement while also providing biobank users a detailed understanding of sample quality.

This webinar is hosted by Agilent Technologies

Agilent Technologies
July, 2020
July 8, TIME TBD

Workshop: Assessing and Addressing the Ethical and Governance Challenges of Networking Biorepositories

Presented by Aaron J Goldenberg (Case Western University, USA), Kyle Brothers (University of Louisville, USA), Jean Cadigan (University of North Carolina, USA)

Description: Research in precision medicine aims to identify subsets of patients who share the same biological mechanisms for their disease, and are thus more likely to respond to the same targeted therapies. To achieve this level of personalized health care, researchers need large collections of biospecimens and associated data. While there are a number of large cohorts at individual institutions across the country, individual biobanks and repositories may not provide the diversity and size needed to support further development of precision medicine.

To address this need, many research institutions and smaller biobanks are promoting the networking of multiple biorepositories within or across institutions. This networked biorepository approach permits researchers to access larger, more diverse sets of data and biospecimens through one common interface, while leveraging and preserving the relationships local institutions have built with their communities of donors. However, with these benefits come a number of challenges related to the ethical, regulatory, and governance needs for establishing and maintaining a successful biobank network. This workshop will explore the unique ethical and governance questions raised by networked biorepositories.

Registration Not Available

*workshops only available to full series registrants


July 16, 10:00am PT/1:00pm ET/7:00pm CET/1:00am next day CST

Biospecimens for Accelerating Biomarker Discovery to Advance Diagnosis and Therapeutics

Presented by Ida Biunno (ISENET Biobanking, Italy), Stephen Lin (California Institute for Regenerative Medicine, USA), Lauren Leiman (BloodPAC, USA), Jerry Lee (University of Southern California, USA), Meri Firpo (Memphis Meats, USA)

Description: Advancing personalised medicine, will require new and effective biomarkers that will aid in early and better diagnosis and the development of efficient new therapies. The hallmark of such advances lies in successful translational research which utilizes human biospecimens. Breakthrough discoveries will therefore require quality biospecimens for the identification, development and validation of new research findings. The session represents a review of biobanking of novel human cell systems for a new generation of cellular therapies and personalised diagnostic testing. Speakers will address the new challenges that these systems bring for biobanks in terms of ethics, data management, preservation technology, quality control and characterisation. They will also present potential new technologies and thinking that will be needed to meet these challenges.

August, 2020
August 12, 6:00am PT/9:00am ET/3:00pm CET/9:00pm CST

Global Biobank Experiences - Navigating Your Biorepository Operations

Presented by Yunice Shao (China National GeneBank, China), Iman Farahat (Egyptian National Cancer Institute, Egypt)

Description: Successful repository operations with a solid base in the implementation of best practices are universal and can be scaled for implementation in any size operation. This session will highlight proven, successful repository operations across the globe. Presentations will demonstrate how repositories stayed relevant and developed coordinated activities to tackle challenges and the changing demands of the scientific communities they serve.


August 19, 8:00am PT/11:00am ET/5:00pm CET/11:00pm CST

Practical Applications for Biorepository Processes

Presented by Umesh Bhanot (Memorial Sloan Kettering Cancer Center, USA), Steven Haynes (Sheffield University Medical School, UK)

Description: Biobanks have been portrayed as having the promise to unlock biological processes and promote a better tomorrow. Following the advent of the human genome project, biobanks have become the bedrock to accelerating scientific discoveries. Stemming from the success stories is a blueprint that places the biobank community at the forefront of research infrastructure for many generations to come. Discussions will include utilization of the methods and technology that support acquisition, data annotation, processing, quality control, cryopreservation, and cold-chain logistics.


Date and time to be confirmed

Contributed Paper Session 1

Registration not available

*abstract sessions only available to full series registrants


August 26, Time TBD

Corporate Workshop: 5,000 Days of Biobank Experience - What Have We Learned and How Do We Prepare for the Next Decade?

Presented by: Erik Steinfelder, Thermo Fisher Scientific, The Netherlands

Description: Last year, a study performed by the German Biobank Node (GBN) proved again that researchers are in need of high-quality samples that have been processed and stored under reliable conditions. While this might seem obvious, it is easier said than done for many biobankers. What is the best way to prepare and store samples if you are focusing on specific molecular mechanisms of diseases versus investigation of target expression in large patient cohorts when designing a clinical trial? Before samples are actually stored, it is good to have a clear understanding of their potential use i.e. which analytical technologies will be used. In those cases where the analytical end goal is not clear, consensus should be there on which general storage conditions must apply. In the last decade, hundreds of biobanks around the globe were supported by our cold storage solutions, pre-analytical workflows and -omics technologies. What did we see, learn, develop and improve that could help you achieve the requirements of researchers that are desperately looking for samples and associated clinical data? Join us for an industry perspective presented in an interactive manner that could help you to optimize your approach and processes.

This webinar is hosted by Thermo Fisher Scientific

Thermo Fisher Scientific
September, 2020
Date and time to be confirmed

How Biobanks are Paving a Path to a Better Tomorrow

Presented by: Lester Russell (National Health Service, UK), Dawn Barry (LunaPBC, USA)

More speakers TBC

Description: Research technologies are transforming our biological knowledge-base in ways that have never been possible. As the stewards of quality biospecimens and associated big data, biobanks are providing pathways to diagnostics and discovery that permeate across the globe with the goal of improvement in prevention, wellness, and healthcare applications. The opening plenary of ISBER 2020 aims to provide high-impact scientific narratives in which biobanks have paved the road towards a better tomorrow. Accomplishments in biomarker discovery, community engagement, and advancements in artificial intelligence will be some of the storylines highlighted by speakers who have utilized biobanks for their research.


Date and time to be confirmed

Contributed Paper Session 2

Registration not available

*abstract sessions only available to full series registrants


Date and time to be confirmed

Corporate Workshop: The Importance of Sample Management in Precision Medicine: A High-throughput Biobanking Workflow Solution

Presented by: Andrew Brooks (RUCDR, Brooks Life Sciences, USA)

Description: The increased acceptance and implementation of precision medicine, direct to consumer genomics and applications such as regenerative medicine have driven the need and adoption for the storage of primary samples and the isolation and storage of high quality, high molecular weight nucleic acid. One reason for primary sample and nucleic acid storage is the value of the information held within the sample.

The application of sequencing technologies to research and clinical settings has increased dramatically, generating vast amounts of data about variations in our genomes that could explain some differences in disease susceptibility, progression and how patients react to drugs. The move towards precision medicine and immune modulation therapy development both requiring sequencing in the treatment workflow drive the demand for faster processing, storage and data sample management techniques.

Efficient and effective storage ensuring sample integrity is of the utmost importance; retention of sample information with the associated phenotypic insight can provide a wealth of genetic and environmental information that can be unlocked in an attempt to better understand disease and health. In this workshop we explore industry collaborations to provide a solution to the increased need for efficient sample management and nucleic acid extraction that meet todays increased requirement for higher throughput full workflow solution

This webinar is hosted by PerkinElmer

PerkinElmer
October, 2020
Date and time to be confirmed

Moving Science Forward - Results Drive Value/Reputation of Biobanks and Enhance Sustainability

Presented by Christopher Loffredo (Georgetown University Medical Center, USA), Anderson Mayfield (NOAA/University of Miami, USA), Antonio Hugo Campos (Rede D'Or Network Hospitals, Brazil)

More speakers TBC

Description: Biobanks have become key assets to research and clinical care. Biobanks require financial and operational support from organizations, key stakeholders and the community to be sustained. This plenary symposium will highlight scientific success stories that have resulted from the use of fit for purpose biospecimens and data from biobanks to power their findings and translation into practice. Scientific success feeds back to increase the stature and reputation of biobanks as an important infrastructure in discovery research. Lessons learned from this plenary will be specific examples of how scientific success can be leveraged to increase the value/reputation and financial, operational and social sustainability of biobanks.


Date and time to be confirmed

Contributed Paper Session 3

Registration not available

*abstract sessions only available to full series registrants

Please click here to access available electronic poster abstracts.

The virtual exhibit hall will be available publicly as of July 1, 2020. Check back soon!

More information coming soon!